| Product Code: ETC8543771 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Neuroblastoma Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Neuroblastoma Market - Industry Life Cycle |
3.4 Netherlands Neuroblastoma Market - Porter's Five Forces |
3.5 Netherlands Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Netherlands Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Netherlands Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Netherlands Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of neuroblastoma cases in the Netherlands |
4.2.2 Rising investments in research and development for neuroblastoma treatments |
4.2.3 Technological advancements in diagnosis and treatment options for neuroblastoma |
4.3 Market Restraints |
4.3.1 High treatment costs associated with neuroblastoma therapies |
4.3.2 Limited availability of specialized healthcare facilities for neuroblastoma treatment in the Netherlands |
5 Netherlands Neuroblastoma Market Trends |
6 Netherlands Neuroblastoma Market, By Types |
6.1 Netherlands Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Netherlands Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Netherlands Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Netherlands Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Netherlands Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Netherlands Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Netherlands Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Netherlands Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Netherlands Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Netherlands Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Netherlands Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Netherlands Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Netherlands Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Netherlands Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Netherlands Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Neuroblastoma Market Import-Export Trade Statistics |
7.1 Netherlands Neuroblastoma Market Export to Major Countries |
7.2 Netherlands Neuroblastoma Market Imports from Major Countries |
8 Netherlands Neuroblastoma Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of innovative neuroblastoma treatment options |
8.3 Number of clinical trials for neuroblastoma therapies in the Netherlands |
9 Netherlands Neuroblastoma Market - Opportunity Assessment |
9.1 Netherlands Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Netherlands Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Netherlands Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Netherlands Neuroblastoma Market - Competitive Landscape |
10.1 Netherlands Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here